title: Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.
abstract: In human breast cancer, mutations in the p53 gene are associated with poor prognosis. However, analysis of patient data so far did not clarify, whether missense point mutations in the p53 gene, in addition to causing loss of wild-type p53 function, also confer a gain of function phenotype to the encoded mutant p53. As heterogeneity of patient material and data might obscure a clear answer, we studied the effects of a coexpressed mutant p53(R270H) in transgenic mice in which SV40 early proteins initiate the development of mammary adenocarcinoma (WAP-T mice). In such tumors the endogenous wild-type p53 is functionally compromised by complex formation with SV40 T-antigen, thereby constituting a loss of wild-type p53 function situation that allowed analysis of the postulated gain of function effects of mutant p53(R270H). We found that mutant p53(R270H) in bi-transgenic mice enhanced the transition from intraepithelial neoplasia to invasive carcinoma, resulting in a higher frequency of invasive carcinoma per gland and per mouse, a more severe tumor phenotype, and more frequent pulmonary metastasis. Surprisingly, mutant p53(R270H) in this system does not increase genomic instability. Therefore, other postulated gain of function activities of mutant p53 must be responsible for the effects described here.
authors: Department of Tumor Virology, Heinrich-Pette-Institute for Experimental Virology and Immunology, Martinistrasse 52, Hamburg, Germany.
authors: Christina
authors: C
authors: Heinlein
authors: Frauke
authors: F
authors: Krepulat
authors: Jürgen
authors: J
authors: Löhler
authors: Daniel
authors: D
authors: Speidel
authors: Wolfgang
authors: W
authors: Deppert
authors: Genrich V
authors: GV
authors: Tolstonog
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics*; D000818:Animals; D000952:Antigens, Polyomavirus Transforming; D001120:Arginine; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D004195:Disease Models, Animal; D018450:Disease Progression; D005260:Female; D016158:Genes, p53; D006639:Histidine; D008175:Lung Neoplasms / Q000556:secondary; D008325:Mammary Neoplasms, Experimental / Q000235:genetics* / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008822:Mice, Transgenic; D020125:Mutation, Missense; D009857:Oncogenes; D010641:Phenotype; D017354:Point Mutation; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D000952:Antigens, Polyomavirus Transforming; D016159:Tumor Suppressor Protein p53; D006639:Histidine; D001120:Arginine